Sinopharm Group (01099) Announces Director Appointments and Schedules EGM

Bulletin Express12-04

Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General Meeting (EGM) set for 19 December 2025 at 9:30 a.m., to be held at Meeting Room 1401 in Sinopharm Group Building, Shanghai.

According to the circular, three individuals, namely Jin Bin, Ma Yue, and Li Ying, have been nominated for non-executive director positions. All three are subject to shareholder approval and will serve until the end of the current Board session, with no remuneration expected under the company's existing guidelines for non-executive directors.

Additionally, the circular proposes the appointment of Yang Binghua as an executive director. Yang currently serves as a deputy secretary of the Party Committee within the Group. Should the nomination be approved, Yang’s term will also run through the remainder of the current Board session, following the company's standard remuneration policies for executive directors.

Shareholders registered by 16 December 2025 are eligible to attend and vote at the EGM. The circular contains detailed procedures for proxy appointments, voting, and confirmation of share ownership, ensuring that shareholders can participate fully in the upcoming vote.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104227863?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 06:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104227863","market":"hk","top_or_hot":-1,"title":"Sinopharm Group (01099) Announces Director Appointments and Schedules EGM","media":"Bulletin Express","content":"<p>Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General Meeting (EGM) set for 19 December 2025 at 9:30 a.m., to be held at Meeting Room 1401 in Sinopharm Group Building, Shanghai.</p>\n<p>According to the circular, three individuals, namely Jin Bin, Ma Yue, and Li Ying, have been nominated for non-executive director positions. All three are subject to shareholder approval and will serve until the end of the current Board session, with no remuneration expected under the company's existing guidelines for non-executive directors.</p>\n<p>Additionally, the circular proposes the appointment of Yang Binghua as an executive director. Yang currently serves as a deputy secretary of the Party Committee within the Group. Should the nomination be approved, Yang’s term will also run through the remainder of the current Board session, following the company's standard remuneration policies for executive directors.</p>\n<p>Shareholders registered by 16 December 2025 are eligible to attend and vote at the EGM. The circular contains detailed procedures for proxy appointments, voting, and confirmation of share ownership, ensuring that shareholders can participate fully in the upcoming vote.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Group (01099) Announces Director Appointments and Schedules EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Group (01099) Announces Director Appointments and Schedules EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 06:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General Meeting (EGM) set for 19 December 2025 at 9:30 a.m., to be held at Meeting Room 1401 in Sinopharm Group Building, Shanghai.</p>\n<p>According to the circular, three individuals, namely Jin Bin, Ma Yue, and Li Ying, have been nominated for non-executive director positions. All three are subject to shareholder approval and will serve until the end of the current Board session, with no remuneration expected under the company's existing guidelines for non-executive directors.</p>\n<p>Additionally, the circular proposes the appointment of Yang Binghua as an executive director. Yang currently serves as a deputy secretary of the Party Committee within the Group. Should the nomination be approved, Yang’s term will also run through the remainder of the current Board session, following the company's standard remuneration policies for executive directors.</p>\n<p>Shareholders registered by 16 December 2025 are eligible to attend and vote at the EGM. The circular contains detailed procedures for proxy appointments, voting, and confirmation of share ownership, ensuring that shareholders can participate fully in the upcoming vote.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1104227863","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104227863","pubTimestamp":1764800668,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"国药集团(01099)公布董事委任及安排临时股东大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"Sinopharm Group Co. Ltd. (01099) has released a circular announcing proposed appointments of non-executive and executive directors. The appointments will be voted on at an Extraordinary General Meeting (EGM) set for 19 December 2025 at 9:30 a.m., to be held at Meeting Room 1401 in Sinopharm Group Building, Shanghai.\nAccording to the circular, three individuals, namely Jin Bin, Ma Yue, and Li Ying, have been nominated for non-executive director positions. All three are subject to shareholder approval and will serve until the end of the current Board session, with no remuneration expected under the company's existing guidelines for non-executive directors.\nAdditionally, the circular proposes the appointment of Yang Binghua as an executive director. Yang currently serves as a deputy secretary of the Party Committee within the Group. Should the nomination be approved, Yang’s term will also run through the remainder of the current Board session, following the company's standard remuneration policies for executive directors.\nShareholders registered by 16 December 2025 are eligible to attend and vote at the EGM. The circular contains detailed procedures for proxy appointments, voting, and confirmation of share ownership, ensuring that shareholders can participate fully in the upcoming vote.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104227863","isCrawlerRequest":true}